Swedish Orphan Biovitrum AB (publ)

SOBI.ST·Stockholm·Healthcare

Compare

494.20+11.60 (+2.40%)today

As of Nov 5, 1:03 PM CET · May be delayed up to 15 min · SEK

Key statistics

Previous close482.60

Open486.00

Day range484.20494.60

52-week range314.40494.60

Off day high−0.08%

Off 52-week high−0.08%

Volume55.99K

Avg. volume (3M)308.51K

Market cap171.98B

EPS (TTM)18.94

Forward P/E31.78

P/E ratio (TTM)26.09

Dividend yield—

Beta (5Y)0.34

Shares outstanding348.00M

Short interest—

Earnings dateOct 27, 2026

Analyst target508.50

Profit margin20.73%

Against its peers

Compare in full ›

	SOBI.ST	ALVO	BCRX	GUD.TO	MDP.TO	AKBA
Market cap	171.98B	1.67B	2.11B	1.11B	158.39M	192.51M
P/E (TTM)	26.1	—	—	75.3	—	—
Forward P/E	31.8	20.3	10.0	43.5	-252.0	-1.9
Price/book	3.8	-8.7	-14.7	1.4	2.4	7.6
Dividend yield	—	—	—	—	—	—
1-year change	+46.60%	−7.71%	+17.21%	+86.16%	+90.19%	−65.75%
Today	+2.40%	+2.86%	−3.85%	+0.36%	+1.41%	−4.28%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Swedish Orphan Biovitrum AB (publ)'s by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
AlvotechALVO · Drug Manufacturers - Specialty & Generic	1.67B	4.6700	+2.86%
BioCryst Pharmaceuticals, Inc.BCRX · Drug Manufacturers - Specialty & Generic	2.11B	8.24	−3.85%
Knight Therapeutics Inc.GUD.TO · Drug Manufacturers - Specialty & Generic	1.11B	11.30	+0.36%
Medexus Pharmaceuticals Inc.MDP.TO · Drug Manufacturers - Specialty & Generic	158.39M	5.04	+1.41%
Akebia Therapeutics, Inc.AKBA · Drug Manufacturers - Specialty & Generic	192.51M	0.6947	−4.28%
Amgen Inc.AMGN · Drug Manufacturers - General	258.68B	478.48	+3.73%
Novartis AGNVS · Drug Manufacturers - General	311.59B	164.98	+3.59%
Biogen Inc.BIIB · Drug Manufacturers - General	37.61B	254.46	+2.22%

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company	Mkt cap	Price	Today
DAE HWA Pharmaceutical Co., Ltd.067080.KQ · Seoul, South Korea	169.30B	9,190.00	−0.11%
Eris Lifesciences LimitedERIS.BO · Ahmedabad, India	170.64B	1,229.95	+1.03%
Yungjin Pharm. Co., Ltd.003520.KS · Seoul, South Korea	155.64B	851.00	−3.30%
Samil Pharmaceutical Co.,Ltd000520.KS · Seoul, South Korea	166.26B	7,780.00	+1.43%
Towa Pharmaceutical Co., Ltd.4553.T · Kadoma, Japan	179.68B	3,650.00	+3.84%
AstraZeneca Pharma India LimitedASTRAZEN.NS · Bengaluru, India	157.35B	6,294.00	−1.16%
Alembic Pharmaceuticals LimitedAPLLTD.BO · Vadodara, India	176.07B	895.75	−1.26%
Caplin Point Laboratories LimitedCAPLIPOINT.NS · Chennai, India	184.05B	2,421.40	+0.22%

Healthcare companies of a similar market value (166.76B).

Company	Mkt cap	Price	Today
Abbott LaboratoriesABL.F · Medical Devices	177.10B	102.35	−0.44%
DAE HWA Pharmaceutical Co., Ltd.067080.KQ · Drug Manufacturers - Specialty & Generic	169.30B	9,190.00	−0.11%
Eris Lifesciences LimitedERIS.BO · Drug Manufacturers - Specialty & Generic	170.64B	1,229.95	+1.03%
Syngene International LimitedSYNGENE.BO · Diagnostics & Research	166.51B	414.30	−0.70%
GNI Group Ltd.2160.T · Biotechnology	156.64B	2,380.00	−0.50%
Pfizer Inc.PFE · Drug Manufacturers - General Odds	175.50B	30.79	+2.63%
DexCom, Inc.D1EX34.SA · Medical Devices	175.85B	9.43	+3.29%
Yungjin Pharm. Co., Ltd.003520.KS · Drug Manufacturers - Specialty & Generic	155.64B	851.00	−3.30%

Also based in Stockholm, Sweden, then elsewhere in Sweden.

Company	Mkt cap	Price	Today
Spotify Technology S.A.SPOT · Stockholm, Sweden Odds	129.04B	627.66	+4.59%
Investor AB (publ)IVS.F · Stockholm, Sweden	120.06B	39.19	+0.38%
Sandvik AB (publ)0HC0.IL · Stockholm, Sweden	501.95B	367.90	+1.22%
Svenska Handelsbanken AB (publ)0R7R.IL · Stockholm, Sweden	314.76B	161.85	+1.23%
ASSA ABLOY AB (publ)0R87.IL · Stockholm, Sweden	465.52B	401.50	+0.48%
Skandinaviska Enskilda Banken AB (publ)0HBY.IL · Stockholm, Sweden	449.89B	217.35	+1.23%
Telefonaktiebolaget LM Ericsson (publ)0O87.IL · Stockholm, Sweden	374.51B	104.20	−3.43%
EQT AB (publ)EQT.ST · Stockholm, Sweden	401.81B	322.50	+0.81%

Companies that serve the same markets: healthcare.

Company	Mkt cap	Price	Today
Emcure Pharmaceuticals LimitedEMCURE.BO · healthcare	424.98B	2,240.15	+3.02%
Intuitive Surgical, Inc.I1SR34.SA · healthcare	935.13B	132.35	+7.60%
PT Prodia Widyahusada TbkPRDA.JK · healthcare	3.20T	3,650.00	−1.35%
PT Mitra Keluarga Karyasehat TbkMIKA.JK · healthcare	18.26T	1,315.00	+1.15%
Ventas, Inc.V1TA34.SA · healthcare	244.47B	231.15	0.00%
Krishna Institute of Medical Sciences LimitedKIMS.BO · healthcare	306.90B	730.70	−1.24%
Eris Lifesciences LimitedERIS.NS · healthcare	170.63B	1,229.90	+1.23%
GC Biopharma Corp.006280.KS · healthcare	1.62T	142,300.00	+2.67%

What visitors to Swedish Orphan Biovitrum AB (publ)'s page also look at.

Company	Mkt cap	Price	Today
Getinge AB ser. BGETI-B.ST	76.86B	282.20	+1.15%
Elekta AB ser. BEKTA-B.ST	23.35B	61.10	+1.58%
Sandvik ABSAND.ST	460.61B	367.20	+1.41%
SKF, AB ser. BSKF-B.ST	126.04B	276.80	+0.73%
Skanska AB ser. BSKA-B.ST	117.81B	284.50	−0.66%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All SOBI.ST news ›

Seeking Alpha·Oct 27Positive

Swedish Orphan Biovitrum AB (publ) (SWOBY) Q3 2026 Earnings Call Transcript

Swedish Orphan Biovitrum AB (publ) (SWOBY) Q3 2026 Earnings Call October 27, 2026 10:00 AM EDTCompany ParticipantsGuido Oelkers - CEO & PresidentLydia... Swedish Orphan Biovitrum AB (publ) (SWOBY) Q3 2026 Earnings Call October 27, 2026…

From the 4Search news index, newest first.

In the news

2mentions in 30 days

2with it in the headline

Positivesentiment

Most coverage from

seekingalpha.com2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

About

Profile ›

Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.

From Wikipedia, CC BY-SA 4.0

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Chief executiveGuido Oelkers Ph.D.

Employees2,207

HeadquartersStockholm, Sweden

Websitesobi.com

Analyst ratings

Analysis ›

Buy12 analysts

Strong buy 3
Buy 4
Hold 5
Sell 0
Strong sell 0

12-month price target508.50+2.89%

Low 308.00Current 494.20High 600.00

Wall Street analyst consensus. Not a recommendation.

Earnings

Reported EPS
Estimate

Next report: Tue, Oct 27, 2026

Quarterly results

Financials ›

Revenue
Net income
Net margin 25.8% (Q3 '26)

Prices may be delayed up to 15 min. Not investment advice.

Funds that hold it

First Trust IPOX Europe Equity Opportunities ETFFPXE6.23%

Share of each fund, from the issuers' daily holdings files.

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance